Mirati Therapeutics | MRTX - Market Capitalization


Mirati Therapeutics reported $4.12B in Market Capitalization this January of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Astellas Pharma JPY 4.56T 770.92B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bayer EUR 37.69B 1.01B May/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eisai JPY 1.25T 171.13B May/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Exelixis USD 14.34B 3.44B May/2026
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Incyte USD 21.73B 3B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 147.4B 6.42B May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.16B 123M May/2026
Takeda JPY 8.33T 681.01B May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026